IQVIA CEO Ari Bousbib Sells $26.1 Million in Stock

IQVIA Holdings Inc. Chairman and CEO Ari Bousbib sold approximately 106,000 shares of company stock for $26.1 million on July 29, 2026. The transaction involved the exercise and sale of stock appreciation rights that were scheduled to expire in February 2027. This move reduced his direct holdings by 11%, though he retains a total beneficial position of 1.4 million shares, which includes 543,000 shares held indirectly through the Orohena Trust.

The sale occurred after the company reported a strong second quarter characterized by record clinical bookings of $3.15 billion and revenue growth of 8.7%, totaling $4.37 billion. Based on these results, the company increased its full-year guidance to as much as $17.475 billion, although the company noted that cash flow performance did not meet expectations.